Computational Drug Discovery Methods

Computational drug discovery uses mathematical models and algorithms to predict how small molecules interact with biological targets, replacing or augmenting the slower process of testing compounds purely in the laboratory. Techniques like molecular docking estimate the binding geometry of a candidate drug within a protein's active site, while quantitative structure-activity relationship (QSAR) modeling encodes chemical structure as numerical features to predict potency, toxicity, or pharmacokinetic behavior before any synthesis takes place. Machine learning has substantially expanded the scale and accuracy of virtual screening, allowing researchers to rank millions of compounds rapidly, though a persistent challenge is ensuring that models generalize reliably to chemical regions of space not well represented in training data. An active frontier involves polypharmacology — designing molecules that engage multiple targets simultaneously — which demands new computational frameworks capable of reasoning about network-level effects in disease biology rather than the binding affinity of a single protein-ligand pair.

Works

173,377

Total citations

3,141,153

Keywords

Molecular DockingVirtual ScreeningDrug Target IdentificationQSAR ModelingPharmacokineticsChemical Properties